Implications of a vasodilatory human monoclonal autoantibody in postural hypotension

Journal of Biological Chemistry

Volumn 288, Issue 42, 2013, Pages 30734-30741

  Li, Hongliang ^a,b   Zuccolo, Jonathan ^a   Kem, David C ^a,b   Zillner, Caitlin ^a,b   Lee, Jiyeon ^a   Smith, Kenneth ^c   James, Judith A ^a,c   Cunningham, Madeleine W ^a   Yu, Xichun ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTORS; AUTOANTIBODIES; CARDIO-VASCULAR DISEASE;

BIOCHEMISTRY; BIOLOGY;

ANTIGENS;

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; AUTOANTIBODY; BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; EPITOPE; IMMUNOGLOBULIN G3; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY C5F2; UNCLASSIFIED DRUG;

ADULT; ALPHA ADRENERGIC STIMULATION; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CASE REPORT; CELL STRAIN; DRUG TARGETING; GENETIC TRANSFECTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LYMPHOCYTE; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RECEPTOR BINDING; SURFACE PLASMON RESONANCE; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ADRENERGIC RECEPTOR; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; HUMAN MONOCLONAL AUTOANTIBODY; PATHOGENESIS; POSTURAL HYPOTENSION; VASCULAR; VASODILATORY;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTIBODIES, MONOCLONAL; AORTA; ARTERIOLES; AUTOANTIBODIES; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; HYPOTENSION, ORTHOSTATIC; IMMUNOGLOBULIN G; MALE; MYOCYTES, CARDIAC; PEPTIDES; PROPANOLAMINES; RATS; RECEPTORS, ADRENERGIC, BETA-2; SURFACE PLASMON RESONANCE; VASODILATOR AGENTS;

EID: 84886889283     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.477869     Document Type: Article

References (39)

1. Magnusson, Y., Wallukat, G., Waagstein, F., Hjalmarson, A., and Hoebeke, J. (1994) Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the β1-adrenoceptor with positive chronotropic effect. Circulation 89, 2760-2767
2. Jahns, R., Boivin, V., Siegmund, C., Inselmann, G., Lohse, M. J., and Boege, F. (1999) Autoantibodies activating human β1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 99, 649-654
3. Wallukat, G., Fu, H. M., Matsui, S., Hjalmarson, A., and Fu, M. L. (1999) Autoantibodies against M2 muscarinic receptors in patients with cardiomyopathy display non-desensitized agonist-like effects. Life Sci. 64, 465-469
4. Wallukat, G., Morwinski, M., Kowal, K., Förster, A., Boewer, V., and Wollenberger, A. (1991) Autoantibodies against the β-adrenergic receptor in human myocarditis and dilated cardiomyopathy: β-adrenergic agonism without desensitization. Eur. Heart J. 12, 178-181
5. Mascaro-Blanco, A., Alvarez, K., Yu, X., Lindenfeld, J., Olansky, L., Lyons, T., Duvall, D., Heuser, J. S., Gosmanova, A., Rubenstein, C. J., Cooper, L. T., Kem, D. C., and Cunningham, M. W. (2008) Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity 41, 442-453
6. Fu, M. L., Herlitz, H., Wallukat, G., Hilme, E., Hedner, T., Hoebeke, J., and Hjalmarson, A. (1994) Functional autoimmune epitope on α1-adrenergic receptors in patients with malignant hypertension. Lancet 344, 1660- 1663
7. Luther, H. P., Homuth, V., and Wallukat, G. (1997) α1-Adrenergic receptor antibodies in patients with primary hypertension. Hypertension 29, 678-682
8. Wenzel, K., Haase, H., Wallukat, G., Derer, W., Bartel, S., Homuth, V., Herse, F., Hubner, N., Schulz, H., Janczikowski, M., Lindschau, C., Schroeder, C., Verlohren, S., Morano, I., Muller, D. N., Luft, F. C., Dietz, R., Dechend, R., and Karczewski, P. (2008) Potential relevance of α1-adrenergic receptor autoantibodies in refractory hypertension. PLoS ONE 3, e3742
9. Chiale, P. A., Ferrari, I., Mahler, E., Vallazza, M. A., Elizari, M. V., Rosenbaum, M. B., and Levin, M. J. (2001) Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 103, 1765-1771
10. Chiale, P. A., Garro, H. A., Schmidberg, J., Sánchez, R. A., Acunzo, R. S., Lago, M., Levy, G., and Levin, M. (2006) Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac β-adrenergic receptors. Heart Rhythm 3, 1182-1186
11. Baba, A., Yoshikawa, T., Fukuda, Y., Sugiyama, T., Shimada, M., Akaishi, M., Tsuchimoto, K., Ogawa, S., and Fu, M. (2004) Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur. Heart J. 25, 1108-1115
12. Stavrakis, S., Yu, X., Patterson, E., Huang, S., Hamlett, S. R., Chalmers, L., Pappy, R., Cunningham, M. W., Morshed, S. A., Davies, T. F., Lazzara, R., and Kem, D. C. (2009) Activating autoantibodies to the β1-adrenergic and M2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism. J. Am. Coll. Cardiol. 54, 1309-1316
13. Wallukat, G., Nissen, E., Morwinski, R., and Müller, J. (2000) Autoantibodies against the β and muscarinic receptors in cardiomyopathy. Herz 25, 261-266
14. Dragun, D., Philippe, A., Catar, R., and Hegner, B. (2009) Autoimmune mediated G-protein receptor activation in cardiovascular and renal pathologies. Thromb. Haemost. 101, 643-648
15. Jahns, R., Boivin, V., Hein, L., Triebel, S., Angermann, C. E., Ertl, G., and Lohse, M. J. (2004) Direct evidence for a β1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J. Clin. Invest. 113, 1419-1429
16. Li, H., Scherlag, B. J., Kem, D. C., Zillner, C., Male, S., Thirunavukkarasu, S., Shen, X., Pitha, J. V., Cunningham, M. W., Lazzara, R., and Yu, X. (2013) Atrial tachycardia provoked in the presence of activating autoantibodies to β2-adrenergic receptor in the rabbit. Heart Rhythm 10, 436-441
17. Fu, M. L., Schulze, W., Wallukat, G., Hjalmarson, A., and Hoebeke, J. (1996) A synthetic peptide corresponding to the second extracellular loop of the human M2 acetylcholine receptor induces pharmacological and morphological changes in cardiomyocytes by active immunization after 6 months in rabbits. Clin. Immunol. Immunopathol. 78, 203-207
18. Matsui, S., Fu, M. L., Katsuda, S., Hayase, M., Yamaguchi, N., Teraoka, K., Kurihara, T., Takekoshi, N., Murakami, E., Hoebeke, J., and Hjalmarson, A. (1997) Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J. Mol. Cell. Cardiol. 29, 641-655
19. Zhou, Z., Liao, Y. H., Wei, Y., Wei, F., Wang, B., Li, L., Wang, M., and Liu, K. (2005) Cardiac remodeling after long-term stimulation by antibodies against the α1-adrenergic receptor in rats. Clin. Immunol. 114, 164-173
20. Wenzel, K., Wallukat, G., Qadri, F., Hubner, N., Schulz, H., Hummel, O., Herse, F., Heuser, A., Fischer, R., Heidecke, H., Luft, F. C., Muller, D. N., Dietz, R., and Dechend, R. (2010) α1A-adrenergic receptor-directed autoimmunity induces left ventricular damage and diastolic dysfunction in rats. PLoS ONE 5, e9409
21. Yu, X., Stavrakis, S., Hill, M. A., Huang, S., Reim, S., Li, H., Khan, M., Hamlett, S., Cunningham, M. W., and Kem, D. C. (2012) Autoantibody activation of β-adrenergic and muscarinic receptors contributes to an "autoimmune" orthostatic hypotension. J. Am. Soc. Hypertens. 6, 40-47
22. Li, H., Kem, D. C., Reim, S., Khan, M., Vanderlinde-Wood, M., Zillner, C., Collier, D., Liles, C., Hill, M. A., Cunningham, M. W., Aston, C. E., and Yu, X. (2012) Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism. Hypertension 59, 402-408
23. Adderson, E. E., Shikhman, A. R., Ward, K. E., and Cunningham, M. W. (1998) Molecular analysis of polyreactive monoclonal antibodies from rheumatic carditis: human anti-N-acetylglucosamine/anti-myosin antibody V region genes. J. Immunol. 161, 2020-2031
24. 2+]i are not obligatory for myogenic constriction. Am. J. Physiol. Heart Circ. Physiol. 278, H345-H352
25. Smith, K., Garman, L., Wrammert, J., Zheng, N. Y., Capra, J. D., Ahmed, R., and Wilson, P. C. (2009) Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat. Protoc. 4, 372-384
26. Ye, J., Ma, N., Madden, T. L., and Ostell, J. M. (2013) IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res. 41, W34-W40
27. Giudicelli, V., Chaume, D., and Lefranc, M. P. (2004) IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res. 32, W435-W440
28. Brochet, X., Lefranc, M. P., and Giudicelli, V. (2008) IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36, W503-W508
29. Lebesgue, D., Wallukat, G., Mijares, A., Granier, C., Argibay, J., and Hoebeke, J. (1998) An agonist-like monoclonal antibody against the human β2-adrenoceptor. Eur. J. Pharmacol. 348, 123-133
30. Benovic, J. L., Shorr, R. G., Caron, M. G., and Lefkowitz, R. J. (1984) The mammalian β2-adrenergic receptor: purification and characterization. Biochemistry 23, 4510-4518
31. McLachlan, S. M., and Rapoport, B. (2004) Thyroid stimulating monoclonal antibodies: overcoming the road blocks and the way forward. Clin. Endocrinol. 61, 10-18
32. Sanders, J., Evans, M., Premawardhana, L. D., Depraetere, H., Jeffreys, J., Richards, T., Furmaniak, J., and Rees Smith, B. (2003) Human monoclonal thyroid stimulating autoantibody. Lancet 362, 126-128
33. Hoebeke, J. (1996) Structural basis of autoimmunity against G protein coupled membrane receptors. Int. J. Cardiol. 54, 103-111
34. Peter, J. C., Eftekhari, P., Billiald, P., Wallukat, G., and Hoebeke, J. (2003) scFv single chain antibody variable fragment as inverse agonist of the β2-adrenergic receptor. J. Biol. Chem. 278, 36740-36747
35. Milligan, G. (2004) G protein-coupled receptor dimerization: function and ligand pharmacology. Mol. Pharmacol. 66, 1-7
36. Mijares, A., Lebesgue, D., Wallukat, G., and Hoebeke, J. (2000) From agonist to antagonist: Fab fragments of an agonist-like monoclonal anti-β2-adrenoceptor antibody behave as antagonists. Mol. Pharmacol. 58, 373-379
37. Murray, K. J. (1990) Cyclic AMP and mechanisms of vasodilation. Pharmacol. Ther. 47, 329-345
38. Queen, L. R., and Ferro, A. (2006) β-Adrenergic receptors and nitric oxide generation in the cardiovascular system. Cell. Mol. Life Sci. 63, 1070-1083
39. Noda, K., Saad, Y., Graham, R. M., and Karnik, S. S. (1994) The high affinity state of the β2-adrenergic receptor requires unique interaction between conserved and non-conserved extracellular loop cysteines. J. Biol. Chem. 269, 6743-6752